In HCC, it leads to deregulation of the Wnt/β-catenin and NF-κB pathways and inhibition of multiple transcription factors including NF-κB, ultimately inhibition of HCC growth via apoptosis. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.